Viridian Therapeutics Inc (VRDN) |
|
15.37 -0.36 (-2.29%)
|
04-14 06:05 |
|
Open: |
15.27 |
Pre. Close: |
15.73 |
|
High:
|
16 |
Low:
|
15.27 |
|
Volume:
|
13,697 |
Market Cap:
|
111M |
|
|
|
|
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody for the treatment of thyroid eye disease; VRDN-002, a biosuperior IGF-1R antibody; and VRDN-003, an IGF-1R antibody product specifically designed for thyroid eye disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is based in Boulder, Colorado. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
16.02 - 16.098 |
16.098 - 16.175 |
|
Low:
|
15.046 - 15.141 |
15.141 - 15.235 |
|
Close:
|
15.193 - 15.344 |
15.344 - 15.494 |
|
Technical analysis |
as of: 2021-04-13 5:06:48 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 20.24 One year: 22.06 |
| Support: |
Support1: 14.80 Support2: 12.31 |
| Resistance: |
Resistance1: 17.33 Resistance2: 18.89 |
| Pivot: |
16.66 |
| Moving Average: |
MA(5): 16.10 MA(20): 17.02
MA(100): 16.05 MA(250): |
| MACD: |
MACD(12,26): -0.47 Signal(9): -0.29 |
| Stochastic oscillator: |
%K(14,3): 20.38 %D(3): 31.89 |
| RSI: |
RSI(14): 39.34 |
| 52-week: |
High: 25.19 Low: 8.40 Change(%): -7.7 |
| Average Vol(K): |
3-Month: 6836 10-Days: 2407 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.VRDN has closed above bottom band by 12.3%. Bollinger Bands are 39.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 07 Apr 2021
Do Institutions Own Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares? - Simply Wall St
Thu, 25 Mar 2021
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates - GlobeNewswire
Thu, 18 Mar 2021
Will Viridian Therapeutics, Inc. (VRDN) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Tue, 09 Mar 2021
Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update - GlobeNewswire
Wed, 03 Mar 2021
Will Viridian Therapeutics, Inc. (VRDN) Report Negative Q4 Earnings? What You Should Know - Nasdaq
Mon, 22 Feb 2021
Reflecting on Viridian Therapeutics' (NASDAQ:VRDN) Share Price Returns Over The Last Three Years - Yahoo Finance
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Neutral |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
7 |
| Shares Float (M) |
5 |
|
% Held by Insiders
|
4.55 |
|
% Held by Institutions
|
49.55 |
|
Shares Short (K)
|
121 |
|
Shares Short P. Month (K)
|
151 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-3830.38 |
|
Return on Assets (ttm)
|
-31.1 |
|
Return on Equity (ttm)
|
-163.1 |
|
Qtrly Rev. Growth
|
-93.9 |
|
Gross Profit (p.s.)
|
-3.728 |
|
Sales Per Share
|
0.145 |
|
EBITDA (p.s.)
|
-5.530 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-30 |
|
Levered Free Cash Flow (M)
|
-16 |
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
105.83 |
|
Price to Cash Flow
|
-3.73 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2020-11-12 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
